Rate My Professor Ben Halliday

Currently, as a postdoctoral researcher, Halliday's primary project assesses the suitability of first-tier genomic diagnostic tools in New Zealand, particularly investigating their reduced performance in Māori and Pacific peoples to promote equitable clinical outcomes. He contributes to multiple ongoing projects in paediatric genetics, including neurodevelopmental disorders and malformations. His research outputs include high-impact publications such as 'The X-linked filaminopathies: Synergistic insights from clinical and molecular analysis' (Human Mutation, 2020), 'Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism' (American Journal of Human Genetics, 2021), 'Biallelic variants in EFEMP1 in a man with a pronounced connective tissue phenotype' (European Journal of Human Genetics, 2020), and 'Menke-Hennekam syndrome; delineation of domain-specific subtypes with distinct clinical and DNA methylation profiles' (Human Genetics and Genomics Advances, 2024). Halliday has presented seminars, chaired sessions on genomic data ethics and storage, and participated in initiatives like Genomics Aotearoa and the He Kākano Māori variome resource, advancing genomic medicine translation in Aotearoa New Zealand.